reported that NTN1 is elevated in mouse models of endometrial adenocarcinoma (EC),113 skin squamous cell carcinoma (SCC)114 and myeloma tumours98 and that treated intraperitoneally with NP137 is effective in reducing tumour progression. This evidence concerns the gene NTN1 and endometrium adenocarcinoma.